FINISHED DOSAGE FORMULATIONS
Drug : AVAPRO
Dosage Form : TABLET; ORAL
Application Number : 20757
Country : US
Patented : No
Drug : AMARYL
Dosage Form : TABLET; ORAL
Application Number : 20496
Country : US
Patented : No
Drug : CLOMID
Dosage Form : TABLET; ORAL
Application Number : 16131
Country : US
Patented : No
Drug : CANTIL
Dosage Form : SOLUTION; ORAL
Application Number : 10679
Country : US
Patented : No
Drug : CANTIL
Dosage Form : TABLET; ORAL
Application Number : 10679
Country : US
Patented : No
Drug : PRIMAQUINE
Dosage Form : TABLET; ORAL
Application Number : 8316
Country : US
Patented : No
Drug : TRIDIONE
Dosage Form : SOLUTION; ORAL
Application Number : 5856
Country : US
Patented : No
Drug : DEPAKOTE ER
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 21168
Country : US
Patented : No
Drug : TRIDIONE
Dosage Form : TABLET; ORAL
Application Number : 5856
Country : US
Patented : No
Drug : TRIDIONE
Dosage Form : CAPSULE; ORAL
Application Number : 5856
Country : US
Patented : No
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]LACTOSE, UNSPECIFIED FORM
Route : BUCCAL
CAS :
UNII : J2B2A4N98G
Potency Amount : 183.3
Potency Unit : MG

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
LACTOSE, UNSPECIFIED FORM
Route : BUCCAL/SUBLINGUAL
CAS :
UNII : J2B2A4N98G
Potency Amount : 296.7
Potency Unit : MG

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
LACTOSE, UNSPECIFIED FORM
Route : IM - IV
CAS :
UNII : J2B2A4N98G
Potency Amount : 20.35
Potency Unit : %

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
LACTOSE, UNSPECIFIED FORM
Route : IM - IV
CAS :
UNII : J2B2A4N98G
Potency Amount : 0
Potency Unit : NA

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
LACTOSE, UNSPECIFIED FORM
Route : IM - IV - SC
CAS :
UNII : J2B2A4N98G
Potency Amount : 0
Potency Unit : NA

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
LACTOSE, UNSPECIFIED FORM
Route : IM - IV - SC
CAS :
UNII : J2B2A4N98G
Potency Amount : 13.3
Potency Unit : %

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
LACTOSE, UNSPECIFIED FORM
Route : INHALATION
CAS :
UNII : J2B2A4N98G
Potency Amount : 20
Potency Unit : MG

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
LACTOSE, UNSPECIFIED FORM
Route : INHALATION
CAS :
UNII : J2B2A4N98G
Potency Amount : 25
Potency Unit : MG

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
LACTOSE, UNSPECIFIED FORM
Route : INHALATION
CAS :
UNII : J2B2A4N98G
Potency Amount : 9
Potency Unit : %

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
LACTOSE, UNSPECIFIED FORM
Route : INTRACAVITARY
CAS :
UNII : J2B2A4N98G
Potency Amount : 19.38
Potency Unit : %

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
EXCIPIENTS BY APPLICATIONS
MARKET PLACE
REF. STANDARDS & IMPURITIES